Patent foramen ovale and recurrent stroke: another paradoxical twist.

Suppr

超能文献

作者信息

Halperin Jonathan L, Fuster Valentin

出版信息

Circulation. 2002 Jun 4;105(22):2580-2. doi: 10.1161/01.cir.0000020353.63751.2f.

DOI:10.1161/01.cir.0000020353.63751.2f

PMID:12045158

Abstract

摘要

相似文献

Patent foramen ovale and recurrent stroke: another paradoxical twist.

Circulation. 2002 Jun 4;105(22):2580-2. doi: 10.1161/01.cir.0000020353.63751.2f.

Patent foramen ovale and recurrent stroke: closure is the best option: yes.

Stroke. 2004 Mar;35(3):803-4. doi: 10.1161/01.STR.0000117963.58978.40. Epub 2004 Feb 12.

Patent foramen ovale and cryptogenic stroke. A critical review.

J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):34-8. doi: 10.2459/01.JCM.0000247433.82322.df.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events.

Catheter Cardiovasc Interv. 2002 Feb;55(2):189-94. doi: 10.1002/ccd.10067.

Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.

Am J Cardiol. 2007 May 1;99(9):1312-5. doi: 10.1016/j.amjcard.2006.12.055. Epub 2007 Mar 19.

Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2004 Dec 14;63(11):2198-9; author reply 2198-9.

[Cryptogenic stroke and patent foramen ovale].

Ther Umsch. 2003 Sep;60(9):553-61. doi: 10.1024/0040-5930.60.9.553.

Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.

Catheter Cardiovasc Interv. 2007 Jan;69(1):4-5. doi: 10.1002/ccd.20726.

Patent foramen ovale in cryptogenic stroke: current understanding and management options.

Arch Intern Med. 2004 May 10;164(9):950-6. doi: 10.1001/archinte.164.9.950.

引用本文的文献

Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale.

Int J Cardiovasc Imaging. 2017 Aug;33(8):1125-1131. doi: 10.1007/s10554-017-1088-0. Epub 2017 Feb 7.

Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.

Postepy Kardiol Interwencyjnej. 2016;12(1):49-54. doi: 10.5114/pwki.2016.56949. Epub 2016 Feb 11.

"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism.

Postepy Kardiol Interwencyjnej. 2014;10(3):155-60. doi: 10.5114/pwki.2014.45141. Epub 2014 Sep 11.

Hypoxemia from right-to-left shunting through a patent foramen ovale in right ventricular infarction: treatment by revascularization, preload reduction, and, finally, interventional PFO closure.

Clin Res Cardiol. 2006 Dec;95(12):680-4. doi: 10.1007/s00392-006-0442-3. Epub 2006 Sep 28.

Antithrombotic therapy for stroke in young adults.

J Thromb Thrombolysis. 2005 Oct;20(2):127-32. doi: 10.1007/s11239-005-3206-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验